glp 1 and ketosis The effect of GLP-1 mimetics on the involvement of insulin glucagon GLP-1 is having a *moment*

Suspected side effects should be reported through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)

10.1210/jcem.86.3.7330 15

5 , e583e583 (2015)

Saxenda for weight management) Dulaglutide (Trulicity for diabetes only) Tirzepatide (Mounjaro) a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, with distinct pharmacology from pure GLP-1 agonists [2] [3] These medications work by mimicking the action of naturally occurring hormones that regulate blood glucose and appetite

In Alzheimers disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial

Due to the widespread use of GLP-1R agonists to treat metabolic dysfunction, obesity, and T2DM, it remains important to understand the systemic physiology of GLP-1R activity